0001628280-24-002452.txt : 20240129 0001628280-24-002452.hdr.sgml : 20240129 20240129162738 ACCESSION NUMBER: 0001628280-24-002452 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240129 FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leffler Scott J. CENTRAL INDEX KEY: 0001832406 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 24574066 MAIL ADDRESS: STREET 1: C/O CLOVER HEALTH INVESTMENTS, CORP. STREET 2: 3401 MALLORY LANE, SUITE 210 CITY: FRANKLIN STATE: TN ZIP: 37067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 322 NORTH 2200 WEST CITY: SALT LAKE CITY STATE: UT ZIP: 84116 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 322 NORTH 2200 WEST CITY: SALT LAKE CITY STATE: UT ZIP: 84116 4 1 wk-form4_1706563646.xml FORM 4 X0508 4 2024-01-29 0 0000899923 MYRIAD GENETICS INC MYGN 0001832406 Leffler Scott J. 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-01-29 4 A 0 117770 0 A 117770 D Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. By: Justin Hunter For: Scott J. Leffler 2024-01-29